Acologix
Biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Feb 2006.)
Hayward California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$40.0m | Series B | ||
| N/A | $30.0m | Series C | |
| Total Funding | CAD95.5m | ||